This is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for participants with squamous cell carcinomas (HNC) of the head and neck mucosa and skin after curative-intent primary radiation or surgery.
Participants must have histologically or cytologically confirmed squamous cell carcinoma of the head and neck mucosa and skin.
Participants must be age >=18 years.
Participants must be planning to receive curative-intent surgery or radiation-based treatment as part of standard of care treatment.
Participants must have the ability to understand and the willingness to sign a written informed consent document.
None
University of California, San Francisco
Lead sponsor
Haystack Oncology, Inc.
Collaborator